Trade Mark Journal No.2026/040 2 October 2026
WO0000001937979 (5)
Office of origin: United States of America
Date of International Registration:13 August 2026
Date of designation in the UK:
13 August 2026

International priority date claimed: 6 August 2026
(United States of America)
(50035404)
- Class 5
- Pharmaceutical preparations for the treatment of cancer and oncological disorders, namely, orally administered BRAF inhibitor therapies.
Fore US Bio Inc.
Representative: Neha Bhalani Chiesa Shahinian & Giantomasi PC, 105 Eisenhower Pkwy, Roseland NJ 07068, UNITED STATES OF AMERICA